[go: up one dir, main page]

Reite et al., 1970 - Google Patents

Mast cell depletion: Effect on the absorption of intraperitoneally injected basic histamine releasing agents

Reite et al., 1970

Document ID
3497534087220181865
Author
Reite O
Hausken O
Publication year
Publication venue
European Journal of Pharmacology

External Links

Snippet

The effect of mast cell depletion on the absorption of basic mast cell degranulating and histamine releasing agents from the peritoneal cavity was studied. After a single intraperitoneal injection of polymixin B, its appearance in the blood was delayed in normal …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Similar Documents

Publication Publication Date Title
Katznelson et al. Control of nosema disease of honeybees with fumagillin
Clausen et al. Lactulose, disaccharides and colonic flora: clinical consequences
Polak et al. Mode of action of the 2-nitroimidazole derivative benznidazole
Glinsukon et al. Acute toxicity of capsaicin in several animal species
AU7880991A (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
Reite et al. Mast cell depletion: Effect on the absorption of intraperitoneally injected basic histamine releasing agents
KR890001534A (en) Antibacterial FR109615 and its preparation method
DE69026371T2 (en) MEDICINE AND METHOD FOR INHIBITING VASCULARIZATION OF TUMORS
JPH03255033A (en) Treating agent for trichophyton
Menkin Studies on inflammation: XVIII. On the mechanism of leukocytosis with inflammation
DE69509268T2 (en) Lung graft preservative mixture and method for the living preservation of lung grafts
US20010027206A1 (en) Method and composition for treating and preventing pathogenic effects caused by intracellular calcium overload
Murray et al. Effect of ethanol on absorption of iron in rats.
Yeksan et al. Effect of recombinant human erythropoietin (r-HuEPO) therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactin levels in hemodialysis patients
Lowenthal et al. The inhibition of hyaluronidase by sodium salicylate and its possible metabolites
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
Marsden et al. The effect of prostaglandin D2 (PGD2) on circulating eosinophils
Guillot et al. Chloramphenicol and oxytetracycline residues in milk and tissues from cows and bullocks treated with an injectable formulation
Goodman Development of methods for use of antibiotics to control fireblight (Erwinia amylovora)
AU599129B2 (en) Stabilized growth hormone compositions
Shah Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetic
Chaudry Cellular energetics and ATP-MgCl2 therapy in sepsis
DE1115888B (en) Process for the production of a streptokinase preparation
Nakamura et al. Acceleration phenomenon of granuloma formation caused by felt-pellet in rats
Mailman et al. Effects of hemorrhage on intestinal absorption and secretion